Medprin Regenerative Medical Technologies Co. Ltd. Capital Reinvestment Ratio
Medprin Regenerative Medical Technologies Co. Ltd. capital reinvestment ratio. Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Capital Reinvestment Ratio of 0.28x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥116.38 Million) in capital expenditures (CN¥33.16 Million). Check Medprin Regenerative Medical Technologie cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Capital reinvestment ratio of Medprin Regenerative Medical Technologies Co. Ltd. from 2019 to 2024. This chart tracks Medprin Regenerative Medical Technologies Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. Also explore Medprin Regenerative Medical Technologie annual equity growth to track the company's year-over-year net asset growth rate.
Medprin Regenerative Medical Technologies Co. Ltd. Capital Reinvestment Ratio by Year (2019–2024)
Medprin Regenerative Medical Technologies Co. Ltd. capital reinvestment ratio by year from 2019 to 2024. For the full cash flow conversion analysis, see 301033 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.28x | CN¥116.38 Million | CN¥33.16 Million | ▼ -23.5% |
| 2023 | 0.37x | CN¥107.69 Million | CN¥40.09 Million | ▼ -86.8% |
| 2022 | 2.81x | CN¥48.31 Million | CN¥135.96 Million | ▲ +22.6% |
| 2021 | 2.30x | CN¥66.51 Million | CN¥152.71 Million | ▲ +26.3% |
| 2020 | 1.82x | CN¥33.91 Million | CN¥61.65 Million | ▲ +54.9% |
| 2019 | 1.17x | CN¥31.27 Million | CN¥36.71 Million | — |